These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Current state of the problem of immunopathology of rheumatoid arthritis]. Zborovskiĭ AB; Lempert BA Sov Med; 1980; (6):64-9. PubMed ID: 6447923 [No Abstract] [Full Text] [Related]
5. [Autoimmune mechanism in rheumatoid polyarthritis]. Ciobanu V; Suţeanu S Med Interna (Bucur); 1966 Nov; 18(11):1353-8. PubMed ID: 4167009 [No Abstract] [Full Text] [Related]
6. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797 [TBL] [Abstract][Full Text] [Related]
7. [Dissociation of the rheumatoid factor and the anti-Gm(a) activity of the serum in chronic evolutive polyarthritis]. Audran R; Matte C; Moullec J; Steinbuch M Bibl Haematol; 1965; 23():418-22. PubMed ID: 4160124 [No Abstract] [Full Text] [Related]
8. [Disputable clinical problems of immunopathology of rheumatoid arthritis]. Piaĭ LT Ter Arkh; 1978; 50(9):7-9. PubMed ID: 151945 [No Abstract] [Full Text] [Related]
9. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis]. Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305 [No Abstract] [Full Text] [Related]
10. [The rheumatoid rosette (R. R.) phenomenon in chronic evolutive polyarthritis. (C. E. P.). II. Significance; value in the diagnosis of serum-negative cases]. Delrieu F; Bach JF; Delbarre F Presse Med (1893); 1970 Nov; 78(49):2175-9. PubMed ID: 5481827 [No Abstract] [Full Text] [Related]
11. [The gamma globulina blood groups Gm and Inv. Their relations with chronic progressive polyarthritis]. Brocteur J J Belge Rhumatol Med Phys; 1967; 22(4):169-89. PubMed ID: 4185871 [No Abstract] [Full Text] [Related]
12. [APPROACHES TO THE ETIOLOGY OF CHRONIC EVOLUTIVE POLYARTHRITIS OR RHEUMATOID ARTHRITIS]. MICHOTTE LJ J Belge Med Phys Rhumatol; 1963; 18():149-53. PubMed ID: 14079481 [No Abstract] [Full Text] [Related]
13. Autoantibodies in normals--the value of predicting rheumatoid arthritis. Dörner T; Hansen A Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841 [No Abstract] [Full Text] [Related]
14. [Anti-perinuclear antibodies in the diagnosis and prognosis of rheumatoid polyarthritis]. Youinou P; Le Goff P; Miossec P; L'Hostis D; Pennec Y; Schwarzberg C; Ferrec C Rev Rhum Mal Osteoartic; 1983 May; 50(6):441-6. PubMed ID: 6351234 [TBL] [Abstract][Full Text] [Related]
15. [Etiopathogenesis of chronic evolutive polyarthritis]. Veys E J Belge Rhumatol Med Phys; 1967; 22(6):337-48. PubMed ID: 5621657 [No Abstract] [Full Text] [Related]
17. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033 [TBL] [Abstract][Full Text] [Related]
18. [Immunological research on chronic evolutive polyarthritis. II. Attempted separation of rheumatoid factors]. MOUSTARDIER G; DULONG DE ROSNAY C; DUPASQUIER P; CURCIER H Pathol Biol; 1960 Dec; 8():2243-52. PubMed ID: 24545916 [No Abstract] [Full Text] [Related]
19. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Cojocaru M; Cojocaru IM; Iacob SA Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142 [TBL] [Abstract][Full Text] [Related]
20. [The investigation of the rheumatoid factor as a diagnostic method in chronic evolutive polyarthritis. II]. da CARLOS A GP Gaz Med Port; 1963; 16():15-41. PubMed ID: 14018683 [No Abstract] [Full Text] [Related] [Next] [New Search]